Literature DB >> 2768710

Significance of coronary artery tone in patients with vasospastic angina.

A Hoshio1, H Kotake, H Mashiba.   

Abstract

To investigate the relation between basal coronary artery diameter and development of coronary artery spasm, the diameters of the proximal, middle and distal segments of the three major coronary artery branches, together with that of the left main trunk, were measured on a control angiogram and after ergonovine and nitrate administration in 30 patients with vasospastic angina without significant organic stenosis, and in 35 patients without ischemic heart disease. The percent change in coronary diameter after ergonovine and nitrate administration compared with the control diameter was used as an index of coronary vasoreactivity. In patients with vasospastic angina, coronary artery responses to both ergonovine and nitrate were greater in the spastic segments than in the other segments (p less than 0.05), and those of the coronary arteries without spasm were greater than those of the coronary arteries in patients without ischemic heart disease (p less than 0.01). There were no significant differences between the coronary artery diameters in the two groups after nitrate administration, and the control diameters were less in patients with vasospastic angina than in patients without ischemic heart disease. These observations indicate that a coronary vasomotion disorder, which involves increased basal coronary artery tone and hypersensitivity to vasoconstrictive stimuli, not only at a localized segment but also in the entire coronary artery tree, is present in patients with vasospastic angina. Clinically, evaluation of basal coronary artery tone may be useful for predicting the occurrence and location of coronary artery spasm.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2768710     DOI: 10.1016/0735-1097(89)90100-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Validation of an accurate method for three-dimensional reconstruction and quantitative assessment of volumes, lengths and diameters of coronary vascular branches and segments from biplane angiographic projections.

Authors:  E Wellnhofer; A Wahle; I Mugaragu; J Gross; H Oswald; E Fleck
Journal:  Int J Card Imaging       Date:  1999-10

2.  Relation of basal coronary tone and vasospastic activity in patients with variant angina.

Authors:  Y Ozaki; D Keane; P W Serruys
Journal:  Heart       Date:  1996-03       Impact factor: 5.994

3.  Recurrence of Takotsubo cardiomyopathy with coronary slow flow phenomenon.

Authors:  Tomotake Tokunou; Kenji Sadamatsu
Journal:  J Cardiol Cases       Date:  2012-03-16

4.  A change in the pattern of vasospasm after stenting in a patient with vasospastic angina.

Authors:  Masamichi Wada; Hisao Hara; Masato Nakamura
Journal:  Heart Vessels       Date:  2006-11-27       Impact factor: 2.037

5.  Elevated oxidative stress and endothelial dysfunction in right coronary artery of right ventricular hypertrophy.

Authors:  Xiao Lu; Charles Q Dang; Xiaomei Guo; Sabee Molloi; Cynthia D Wassall; Marvin D Kemple; Ghassan S Kassab
Journal:  J Appl Physiol (1985)       Date:  2011-03-17

6.  Changes of coronary blood flow in vasospastic angina under cold stimulation by transthoracic Doppler echocardiography.

Authors:  Seong Mi Park; Wan Joo Shim; Jung Cheon Ahn; Do Sun Lim; Young Hoon Kim; Young Moo Ro
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

Review 7.  The broken heart-counteraction by SABRES.

Authors:  P G Nixon
Journal:  J R Soc Med       Date:  1993-08       Impact factor: 18.000

8.  Enhanced p122RhoGAP/DLC-1 Expression Can Be a Cause of Coronary Spasm.

Authors:  Takahiko Kinjo; Makoto Tanaka; Tomohiro Osanai; Shuji Shibutani; Ikuyo Narita; Tomohiro Tanno; Kimitaka Nishizaki; Hiroaki Ichikawa; Yoshihiro Kimura; Yuji Ishida; Takashi Yokota; Michiko Shimada; Yoshimi Homma; Hirofumi Tomita; Ken Okumura
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.